Supplementary Figure – Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context
figure
posted on 2022-07-06, 08:38 authored by Taylor & FrancisTaylor & Francis, Antonio Gonzalez-Martın, Ursula A Matulonis, Jacob Korach, Mansoor R Mirza, Kathleen N Moore, Xiaohua Wu, Whitney York, Divya Gupta, Stanislav Lechpammer, Bradley J MonkSupplemental Figure 1. Kaplan–Meier plots of PFS outcomes in patients with BRCAm in (A) PRIMA, (B) NOVA, and (C) NORA studies of niraparib monotherapy, reproduced from [14, 15, 17].
